Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Fluorescein 5-Maleimide (AC177)
Cat.#: ASSD-177
Specifications
Description Fluorescein 5-Maleimide is a protein and peptide fluorescent labeling reagent. 5-MF is a thiol-reactive Fluorescent Probe for bioconjugation. Synonyms 5-MF Size 25 mg Applications Fluorescein 5-Maleimide is a protein fluorescent labeling reagent Molecule Weight 427.36 Molecular formula C24H13NO7 CAS Number 75350-46-8 MDL Number MFCD00077345 Solubility Soluble in water, DMSO, and methanol. Storage Store at -20° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-212 5(6)-Carboxy-2′,7′-dichlorofluorescein diacetate N-succinimidyl ester (AC212) 25 mg inquiry ASSD-228 ImmunoHistoMount (AC228) 30 ml inquiry ASSD-190 Chrysamine G Disodium Salt (AC190) 10 mg, 25 mg inquiry ASSD-101 Cresyl Violet Solution (1%) (AC101) 250 mL, 500 mL, inquiry ASSD-169 Calcium Ionophore A23187 (AC169) 1mg, 5mg, 10 mg inquiry ASSD-118 BrdU (5-Bromo-2′-deoxyuridine) (AC118) 200 mg, 100 mg, 1 g, 5g inquiry ASSD-156 Crystal Violet (AC156) 1g, 5g inquiry ASSD-203 Bis(2,2′-bipyridine)-4,4′-dicarboxybipyridine-ruthenium di(N-succinimidyl ester) bis(hexafluorophosphate) (AC203) 5 mg inquiry ASSD-150 Luminol (AC150) 1 g inquiry ASSD-222 Antifade Fluorescence Mounting Medium with Propidium Iodide (hard set) (AC222) 10 mL inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket